Hyliion (NYSE:HYLN - Get Free Report) is expected to post its quarterly earnings results before the market opens on Tuesday, February 11th. Analysts expect Hyliion to post earnings of ($0.07) per share for the quarter. Investors that wish to register for the company's conference call can do so using this link.
Hyliion Stock Down 4.7 %
Hyliion stock traded down $0.10 during mid-day trading on Friday, reaching $2.01. 1,499,773 shares of the company's stock were exchanged, compared to its average volume of 1,056,439. The company has a fifty day moving average of $2.65 and a 200-day moving average of $2.45. The company has a market cap of $349.20 million, a P/E ratio of -5.43 and a beta of 2.08. Hyliion has a twelve month low of $1.05 and a twelve month high of $4.09.
Insider Activity at Hyliion
In other Hyliion news, Director Vincent T. Cubbage sold 65,000 shares of the business's stock in a transaction that occurred on Friday, November 22nd. The shares were sold at an average price of $3.90, for a total transaction of $253,500.00. Following the completion of the transaction, the director now owns 972,078 shares in the company, valued at $3,791,104.20. The trade was a 6.27 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Jeffrey A. Craig acquired 50,000 shares of Hyliion stock in a transaction dated Wednesday, November 20th. The stock was purchased at an average price of $2.95 per share, for a total transaction of $147,500.00. Following the completion of the acquisition, the director now directly owns 282,060 shares in the company, valued at approximately $832,077. This represents a 21.55 % increase in their position. The disclosure for this purchase can be found here. 20.40% of the stock is currently owned by company insiders.
Hyliion Company Profile
(
Get Free Report)
Further Reading

Before you consider Hyliion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hyliion wasn't on the list.
While Hyliion currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.